Follow
Emilia Hadziyannis
Emilia Hadziyannis
Verified email at med.uoa.gr
Title
Cited by
Cited by
Year
Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir
SJ Hadziyannis, V Sevastianos, I Rapti, D Vassilopoulos, E Hadziyannis
Gastroenterology 143 (3), 629-636. e1, 2012
3912012
Prediction of treatment-related HBsAg loss in HBeAG-negative chronic hepatitis B: a clue from serum HBsAg levels
EK Manesis, ES Hadziyannis, OP Angelopoulou, SJ Hadziyannis
Antiviral therapy 12 (1), 73-82, 2007
2182007
Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection
D Vassilopoulos, A Apostolopoulou, E Hadziyannis, GV Papatheodoridis, ...
Annals of the rheumatic diseases 69 (7), 1352-1355, 2010
1832010
Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity
E Tsochatzis, GV Papatheodoridis, E Hadziyannis, A Georgiou, G Kafiri, ...
Scandinavian journal of gastroenterology 43 (9), 1128-1136, 2008
1302008
Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg‐negative chronic hepatitis B virus infection
GV Papatheodoridis, N Chrysanthos, E Hadziyannis, E Cholongitas, ...
Journal of viral hepatitis 15 (6), 434-441, 2008
1222008
Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B
EK Manesis, GV Papatheodoridis, DG Tiniakos, ES Hadziyannis, ...
Journal of hepatology 55 (1), 61-68, 2011
1132011
Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor …
D Vassilopoulos, N Stamoulis, E Hadziyannis, AJ Archimandritis
The Journal of Rheumatology 35 (7), 1271-1276, 2008
992008
Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring
EK Manesis, M Schina, F Le Gal, O Agelopoulou, C Papaioannou, ...
Antiviral therapy 12 (3), 381-388, 2007
962007
Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial
GV Papatheodoridis, ES Hadziyannis, M Deutsch, SJ Hadziyannis
Official journal of the American College of Gastroenterology| ACG 97 (8 …, 2002
912002
DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B
GV Papatheodoridis, EI Rigopoulou, M Papatheodoridi, K Zachou, ...
Antiviral Therapy 23 (8), 677-685, 2018
892018
Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C
E Tsochatzis, GV Papatheodoridis, V Koliaraki, E Hadziyannis, G Kafiri, ...
Journal of viral hepatitis 17 (11), 800-806, 2010
772010
Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor …
D Vassilopoulos, S Tsikrika, C Hatzara, V Podia, A Kandili, N Stamoulis, ...
Clinical and Vaccine Immunology 18 (12), 2102-2108, 2011
762011
Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy
G Papatheodoridis, J Goulis, S Manolakopoulos, A Margariti, X Exarchos, ...
Journal of Hepatology 60 (1), 62-68, 2014
752014
Splicing variability in HIV type 1 revealed by quantitative RNA polymerase chain reaction
M NEUMANN, J HARRISON, M SALTARELLI, E HADZIYANNIS, V ERFLE, ...
AIDS research and human retroviruses 10 (11), 1531-1542, 1994
751994
Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection
GV Papatheodoridis, E Hadziyannis, E Tsochatzis, N Chrysanthos, ...
Gut 57 (4), 500-506, 2008
722008
Viral biomarkers in chronic HBeAg negative HBV infection
E Hadziyannis, A Laras
Genes 9 (10), 469, 2018
702018
Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease
GV Papatheodoridis, E Hadziyannis, E Tsochatzis, A Georgiou, G Kafiri, ...
Journal of Clinical Gastroenterology 44 (4), e87-e95, 2010
682010
Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases
C Hatzara, E Hadziyannis, A Kandili, C Koutsianas, A Makris, ...
Annals of the rheumatic diseases 74 (10), 1848-1853, 2015
672015
Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection
I Mitroulis, C Hatzara, A Kandili, E Hadziyannis, D Vassilopoulos
Annals of the rheumatic diseases 72 (2), 308-310, 2013
632013
Cross-Class Resistance to Non–β-Lactam Antimicrobials in Extended-Spectrum β-Lactamase–Producing Klebsiella pneumoniae
GW Procop, MJ Tuohy, DA Wilson, D Williams, E Hadziyannis, GS Hall
American journal of clinical pathology 120 (2), 265-267, 2003
592003
The system can't perform the operation now. Try again later.
Articles 1–20